Group sizes of 810 were deemed adequate to detect treatment-related differences as per initial dose-finding glycaemia
GLP-1s are also associated with weight loss, and with less weight, HS patients could see less skin-on-skin friction, improved mobility, and as a result relief from their symptoms
The prescribing clinician is not identified anywhere on the public site
Those with chronic kidney disease require specialized guidance, as high protein intake may not be appropriate
This form will ask you to detail your medical background, current health conditions, and any medications you are currently using
We cannot guarantee Medicare approval, drug availability, copay amount, pharmacy fill timing, or eligibility for the Medicare GLP-1 Bridge Program